微针点阵射频治疗腋臭症的疗效与安全性分析

目的:对微针点阵射频治疗腋臭症的临床疗效和安全性进行分析。方法:对2016年1月—2017年5月收集的45例腋臭患者(参照Park和Shin分级,2级共28例;3级共17例),采用微针点阵射频治疗仪平台进行1次治疗,术后3个月、6个月进行随访。结果:术后3个月随访,治愈30例,有效9例,无效6例,2级组治愈率82.1%,3级组治愈率41.2%,差异有统计学意义(P0.05)。术后6个月随访,治愈27例,有效11例,无效7例,2级组治愈率78.6%,3级组治愈率29.4%,差异有统计学意义(P0.05)。对复发患者于术后3个月进行第2次治疗,随访6个月未见再次复发。术后无1例患者出现感染、血肿及上肢活动障碍等严重并发症。2例患者出现散在的表皮点状烫伤;1例患者腋下治疗区域可触及数枚黄豆大皮下硬结;2例患者出现轻微的单侧上肢麻木,1～3个月后自然消失。结论:微针点阵射频是一种非创伤性的安全、有效的治疗腋臭症的新方法,尤其适用于注重美观的轻、中度腋臭患者。对于重度(3级)腋臭患者建议选择手术治疗。如患者要求行微针点阵射频治疗,提前告知需多次重复治疗。     

黄金微针射频治疗腋臭83例疗效分析

目的探讨黄金微针治疗腋臭疗效及安全性,同时分析不同腋臭分级、性别及体质指数(body mass index,BMI)患者的疗效差异。方法利用BodyTite黄金微针射频仪治疗83例腋臭患者,使用腋臭严重程度分级评价方案对该83例患者术前及术后6个月进行治疗前后疗效评估,总结治疗过程中的并发症,同时记录患者对治疗的满意度评分。依据患者腋臭程度分级、性别、体质指数分别进行分组,对治疗前后疗效、并发症及满意度进行组间比较。结果 83例患者总体有效率为86.75%(72/83)。与轻中度患者比较,重度患者疗效及满意度较低,差异有统计学意义(P0.05)。不同性别患者疗效及并发症差异无统计学意义(P0.05),但女性患者对治疗的满意度较低,差异有统计学意义(P0.05)。与体重正常者及超重者比较,肥胖者疗效及满意度均较低,差异有统计学意义(P0.05)。结论黄金微针治疗腋臭总体疗效好,并发症少,但患者腋臭严重程度及肥胖程度对疗效有一定的影响。     

HE—1型多功能腋臭(美容)治疗仪治疗多发性脂囊瘤38例

HE—Ⅰ型多功能腋臭(美容)治疗仪是用来治疗腋臭的高频电灼仪。作者于1991年9月至1995年1月应用此电灼仪治疗多发性脂囊瘤38例,疗效满意。现报告如下: 一般资料:38例患者均为我科门诊病人。其中男性18例,女性20例;年龄最小13岁,最大48岁;病程最短半年,最长20年;皮损分布;面部8例,颈部5例,前胸6例,背部3     

Body Tite黄金微针射频治疗腋臭48例

目的评价Body Tite黄金微针射频治疗腋臭的临床疗效。方法分析我院收治的48例腋臭患者,按照简单数字原则分为两组,每组24例。对照组应用皮瓣法微创手术治疗,观察组则采用黄金微针射频法治疗,对比不同方法疗效以及安全性。结果观察组与对照组治疗总有效率比较无差异(P 0.05),观察组治疗后的并发症发生率少于对照组(P 0.05)。结论 Body Tite黄金微针射频治疗腋臭,疗效确切显著,而且安全可靠,值得广泛应用。     

BodyTite黄金微针射频治疗腋臭的临床观察

目的探讨黄金微针射频治疗腋臭的有效性、安全性及患者的满意度。方法采用以色列BodyTite黄金微针射频治疗92例腋臭患者。1次治疗后随访3～6个月评定疗效、并发症及复发情况。结果痊愈68例,好转16例,无效8例,总有效率91.3%,轻、中度患者的痊愈率高达87.5%,部分患者出现表皮烫伤、溃疡、上肢麻木等并发症,经对症治疗均治愈。结论 BodyTite黄金微针射频治疗腋臭有创伤小、操作简单、无停工期、不良反应少、表皮损伤轻、复发率低、患者满意度高等优点,适合轻中度腋臭患者,值得临床推广应用。     

两种方法治疗112例包皮讨长尖锐湿疣的疗效对比

为了探讨更有效的治疗途径,我们从1996年10月～2003年10月对112例包皮过长尖锐湿疣(CA)的病人分别用包皮环切加高频电灼术和单纯高频电灼进行疗效比较,前者治疗次数明显减少,首次临床治愈率明显提高.现将治疗结果报道如下.     

微波和黄金微针治疗腋臭的临床疗效比较

【摘要】 目的 比较微波和黄金微针治疗腋臭的临床疗效及安全性。方法 2018 年 5月至 2019 年 3 月在第四军医大学西京医院皮肤科门诊收集不同程度的腋臭患者116例,分别用miraDry微波仪（56例）和黄金微针（60例）治疗,术后随访12个月,观察临床疗效、并发症和复发率。结果 经12个月随访,微波组有效率为94.64％（53例）,复发率为5.36％（3例）;黄金微针组有效率为93.33％（56例）,复发率为6.67％（4例）,两组有效率和复发率差异均无统计学意义（χ2 = 0.088,P = 0.767）。但是,微波组术后并发症发生率为0,黄金微针组为6.67%（2例皮肤烫伤和2例瘢痕形成）,两组差异有统计学意义（χ2 = 3.867,P = 0.049）。结论 黄金微针与微波治疗腋臭临床疗效相当,但微波并发症发生率更低。     

微波治疗腋窝多汗症及腋臭疗效及安全性研究

目的:观察微波治疗腋窝多汗症和腋臭的临床疗效及安全性。方法:20例受试者于肿胀麻醉后采用5.8 GHz微波对双侧腋窝汗腺分布区域进行治疗。观察术前与术后12个月多汗症疾病严重程度量表(HDSS)、Odor-10分量表、Odor-5分量表及腋臭Young-Jin Park分级,记录不良反应,并观察腋毛生长情况。结果:术后12个月,19例(95%)患者HDSS分级下降至1或2级(P0.05);18例(90%)患者腋臭Odor-10分量表评分下降≥50%(P0.05);18例(90%)患者腋臭Odor-5分量表评分下降≥50%(P0.05);16例(80%)患者Young-Jin Park分级降至1级或0级(P0.05)。所有患者均未出现严重不良反应。结论:微波治疗腋窝多汗症及腋臭具有较好的疗效,且不良反应轻微。     

高频电凝治疗腋臭致腋部皮肤坏死原因分析

1988年以来,我们采用西安工业学院和空军西安医院研制的腋臭治疗机(属于高频电凝)治疗腋臭365例,引起3例患者腋部皮肤片状坏死.就其原因分析如下.     

大汗腺清除术加皮瓣原位缝吊法治疗腋臭60例

我科自2007年10月-2008年6月采用微创皮下大汗腺清除术加皮瓣原位缝吊治疗腋臭60例,取得满意疗效. 1 资料与方法 1.1 临床资料 腋臭患者60例,男24例,女36例.年龄22～26岁,平均年龄24岁.其中18例做过电离子电灼治疗.疗效不佳.     

黄金微针射频联合低能量超脉冲CO2点阵激光治疗面部痤疮凹陷性瘢痕的疗效观察

 目的 观察黄金微针射频联合低能量超脉冲CO2点阵激光治疗面部痤疮凹陷性瘢痕的疗效。方法选取2018年4月—2020年4月就诊于河南大学第一附属医院的74例凹陷性痤疮瘢痕患者为对象,随机分为2组,每组各37例。治疗组采用黄金微针射频联合低能量超脉冲CO2点阵激光治疗;对照组采用黄金微针射频治疗。比较2组治疗前后痤疮瘢痕权重评分（ECCA）、瘢痕改善程度IGA评估及术后不良反应。结果2组治疗后ECCA评分均明显降低,但治疗组评分降低更明显(Z=-2.65,P＜0.05);治疗组IGA评估有效率较对照组高。2组不良反应发生率无统计学差异。结论黄金微针射频联合低能量超脉冲CO2点阵激光能更好地改善痤疮后凹陷性瘢痕,两种方法联合能够起到协同作用且不增加治疗相关副作用。     

黄金微针射频与超脉冲CO2点阵激光治疗面部痤疮所致的不同类型凹陷性瘢痕的疗效比较

 目的 比较黄金微针射频与超脉冲CO₂点阵激光治疗不同类型面部凹陷性痤疮瘢痕的临床疗效及安全性。方法 选取我院门诊2019年8月—2021年8月诊治的80例凹陷性痤疮瘢痕患者为研究对象,采用随机数字表法分为治疗组和对照组,每组各40例。治疗组采用黄金微针射频治疗;对照组采用超脉冲CO₂ 点阵激光治疗。比较两组疗效,并按临床亚型（V型、U型和M型）对患者进行分类和评价。结果 两组患者治疗后痤疮瘢痕临床评分量表（ECCA）权重评分均降低,但差异无统计学意义（t=0.46, P=0.644）。 两组患者总体有效率比较差异无统计学意义（X²=1.89,P=0.176）。两组瘢痕亚型比较,治疗组M型瘢痕疗效较好（t=2.34, P＜0.05）,对照组V型瘢痕疗效较好（t=-2.36, P＜0.05）,而两组U型瘢痕疗效无明显差异（t=0.24, P＞0.05）。治疗组患者术中疼痛程度、术后红肿期程度评分均低于对照组,痂皮脱落愈合时间短于对照组,差异均有统计学意义(均P＜0.05)。结论 黄金微针射频与CO₂点阵激光均能有效地改善面部凹陷性痤疮瘢痕,其中前者对M型瘢痕疗效显著,后者对V型瘢痕疗效显著。提示临床工作中可对痤疮瘢痕进行亚型分析,进而选择性治疗,必要时可联合治疗,起到协同作用。     

侵入性微针射频与等离子点阵射频治疗痤疮凹陷性瘢痕的自身对照研究

目的 比较侵入性微针射频与等离子点阵射频治疗面部痤疮凹陷性瘢痕的疗效及安全性。方法 2017年1 - 3月,中南大学湘雅医院皮肤科收集30例痤疮凹陷性瘢痕患者,将每例患者两侧面部按随机数字表分为侵入性微针射频侧与等离子点阵射频侧,治疗间隔8 ~ 12周,共进行3次治疗。治疗前后由研究者采集患者面部照片对瘢痕评分,根据痤疮瘢痕临床分级标准权重评估整体改善度,由医生对皮损改善度进行主观评分;记录治疗后患者的不良反应;患者自评疼痛度及满意度,用德国皮肤生理检测仪记录治疗前后面部表皮含水量、经表皮失水率、皮脂含量等数据。结果 30例患者均完成3次治疗及3次随访。疗效：3次治疗后,侵入性微针射频侧评分为3.00 ± 0.91,22例获得 > 50%改善,而等离子点阵射频侧评分为3.57 ± 0.57,29例获得 > 50%改善,等离子点阵射频总体疗效优于侵入性微针射频（t = 2.894,P = 0.005）。对于Ⅴ型和U型瘢痕,侵入性微针射频侧与等离子点阵射频侧的整体改善率比较,差异无统计学意义（均P > 0.05）,对于M型Rolling瘢痕,侵入性微针射频侧整体改善率为（36.5 ± 2.1）%,低于等离子点阵射频侧［（48.7 ± 3.4）%,P < 0.01］。侵入性微针射频侧疼痛评分为5.54 ± 0.57,明显低于等离子点阵射频侧（8.07 ± 0.79）,差异有统计学意义（P < 0.01）。3次治疗后,侵入性微针射频侧与等离子点阵射频侧的患者满意度比较,差异无统计学意义（χ2 = 0.10,P > 0.05）,表皮含水量、TEWL、皮脂含量等指标差异无统计学意义（均P > 0.05）。两治疗侧均出现红斑、渗出或出血等不良反应。结论 对于V型、U型瘢痕等较小的痤疮瘢痕,等离子点阵射频与侵入性微针射频治疗均可临床应用。而较大的M型Rolling瘢痕,优先选择等离子点阵射频治疗。     

黄金微针射频联合自体富血小板血浆治疗面部痤疮凹陷性瘢痕的疗效评估

目的 探讨黄金微针射频联合自体富血小板血浆(PRP)治疗面部痤疮凹陷性瘢痕的疗效.方法 选择河南大学第一附属医院皮肤科门诊2019年4月-2021年4月接收且诊治的74例凹陷性痤疮瘢痕患者为对象,随机分为2组.观察组采用黄金微针射频联合PRP治疗,对照组采用滚轮微针联合PRP治疗,两组均治疗间隔4周,连续治疗3次,3次...     

Surgical subcision as a cost-effective and minimally invasive treatment for axillary osmidrosis

Background Axillary osmidrosis, characterized by unpleasant odor and occasional staining of clothing, is a personal discomfort and social impairment for people who suffer from it. Various types of surgical procedures involving instrumented‐assisted tools (lasers, ultrasonic, endoscope, and others) have shown relatively positive results; however, for patients in developing countries, especially in China, these treatments are inconvenient and cost‐ineffective. Objective To introduce a minimal incision surgical procedure with skin flap treatment that removes the apocrine sweat glands in the subcutaneous tissue through a 1‐cm‐long incision without instrument‐assisted tools. Method From July 2005 to October of 2007, 108 patients (68 women and 40 men) were treated with the minimal incision and cost‐effective surgical treatment by manual excision. A 1‐cm‐long incision is made in the axillary crease. Subcutaneous tissue and glands were removed with scissors through this incision. This procedure is repeated throughout the entire axilla until the axilla has essentially become a super‐thin flap. Result Malodor elimination was good in 206 out of 215 axillae (95.8%) treated, fair in nine (4.2%), and poor in zero (0%). The resulting scar is small and virtually invisible because it is only 1‐cm long and located in the axillary crease. Conclusion Treatment of axillary osmidrosis by manual excision through a 1‐cm incision is a convenient, efficient, cost‐effective, and relatively safe technique that results in high patient satisfaction and benefits patients and surgeons in developing countries. Axillary osmidrosis, a non‐life‐threatening condition characterized by unpleasant odor and occasional staining of clothing, is an annoying problem, particularly in Asian societies. For many people who suffer from this problem, this condition is a personal discomfort, a social impairment, and discourages patients from enjoying social or personal activities, especially young women. They are usually embarrassed by the smell during their daily activities and communication with other people.     

肿胀麻醉下微切口负压抽刮法治疗腋臭110例

目地 探讨一种微创、有效、安全的腋臭治疗方法。方法 沿腋毛分布边缘标记手术区域,应用肿胀麻醉技术分两层注入肿胀液,分步骤交叉置入抽指针、放射状负压抽刮术区治疗腋臭,术区加压固定。结果 自2009年4月至2010年7月共收治110例,随访3-18个月,总有效率为100％ 。结论 本法操作简单,效果确切,恢复快,术后基本不留皮肤疤痕,值得推广应用。     

两种切口的顶泌汗腺修剪术治疗腋臭的并发症对比分析

目的采用"W"形切口(A组)及"1"字形腋窝皱襞切口(B组)的顶泌汗腺修剪术治疗腋臭,统计分析两组患者术后并发症的发生率。方法回顾分析2011年5月-2013年12月采用两种切口的顶泌汗腺修剪术治疗腋臭163例,其中A组84例,B组79例,对其术后的并发症进行对比分析。结果 A组术后发生血肿5例、皮瓣坏死3例,切口裂开11例,局部瘢痕增生13例,异味残留3例;B组术后发生血肿4例,皮瓣坏死2例,切口裂开3例,局部瘢痕增生4例,异味残留4例。A、B组在切口裂开、局部瘢痕增生的发生率差异有统计学意义(P0.05)。结论 "1"字形腋窝皱襞切口较"W"形切口的顶泌汗腺修剪术在一定程度上可减轻腋臭术后并发症。     

Brachial plexus injury after microwave-based treatment for axillary hyperhidrosis and osmidrosis

Axillary hyperhidrosis combined with osmidrosis is a common problem, especially in Asian communities, that patients find annoying. Even though several surgical techniques have been reported to treat hyperhidrosis/osmidrosis permanently, patients would prefer a non-surgical approach. A microwave-based device was invented during this decade, and it has proven to be a safe and efficient way to treat axillary hyperhidrosis/osmidrosis without major complications. Mild complications reported are vacuum-associated marks, oedema, tenderness and temporary altered skin sensation. We herein report a rare case of brachial plexus injury with sensory and motor dysfunction that occurred after microwave-based treatment. The patient did not fully recover after 6 months of rehabilitation. Our case suggests that a lower initial energy level should be used for thin patients with less fat tissue on the underarm areas, regardless of the patient’s sex.     

Local injection of botulinum toxin A: An alternative therapy for axillary osmidrosis

The objective of this study was to investigate the efficacy of local injection of botulinum toxin A for treating axillary osmidrosis. One hundred and fifty patients with axillary osmidrosis were randomly divided to receive botulinum toxin A injection treatment (50 U of botulinum toxin A was injected intracutaneously into 6–20 different sites within each axilla, n = 74) or surgical excision of the apocrine glands (n = 76). The patients were followed up for 1–3 months to analyze the therapeutic effect and complications of the two methods. The curative effect in patients with mild and moderate axillary osmidrosis was not significantly different between the botulinum toxin A injection group and operation group. However, for patients with severe axillary osmidrosis, surgery treatment seemed to be superior to botulinum toxin A treatment (P = 0.005). There was also no significant difference in the modified Dermatology Life Quality Index between the two treatments. Two cases showed complications related to hemorrhage and incision infection in the operation group. In conclusion, local injection of botulinum toxin A is a safe, fast and effective treatment for mild and moderate axillary osmidrosis, but the long‐term effect remains to be further investigated.     

Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser

Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal coagulation treatment with a 1,444-nm Nd:YAG laser may be the least invasive and most effective therapy for axillary osmidrosis. However, according to our previous experience, the recurrence rate was 20%~30%. This emphasizes the need for combination of surgical method and non-surgical method and we combined subcutaneous tissue removal and photothermocoagulation with a 1,444-nm Nd:YAG laser. Three patients for bilateral axillary osmidrosis were enrolled. After an incision of about one-third the length of the widest transverse diameter, the apocrine glands were separated from the skin. And then apocrine glands within the marked area were destroyed by irradiation with a 1,444-nm Nd:YAG laser thereafter. All patients exhibited no relapse of axillary osmidrosis and were satisfied with the treatment results. A combination of subcutaneous tissue removal and Interstitial laser photothermocoagulation with a 1,444-nm Nd:YAG laser could be an effective treatment for mild to moderate axillary osmidrosis.